Navigation Links
New Heart Pump Helps Women Awaiting Transplants
Date:11/4/2007

It's smaller than the first-generation device, researchers report

SUNDAY, Nov. 4 (HealthDay News) -- An implantable device that helps the heart pump blood -- and is about the size of a "D" battery, one-quarter the weight of the traditional device -- benefits women as well as men who are waiting for heart transplants.

That's the conclusion of new research that's expected to be presented Sunday at the American Heart Association annual meeting in Orlando, Fla.

"In the past, they were not as beneficial in women as in men, partly because of size," said Dr. Suzanne Steinbaum, director of Women and Heart Disease at Lenox Hill Hospital in New York City. "It didn't match up anatomically."

The new device in question, the HeartMate II, is an implantable left ventricular assist device that helps heart function in people with severe congestive heart failure. The U.S. Food and Drug Administration is currently reviewing an application to approve the pump-like device.

According to background information for the study, women with advanced heart failure tended to be underrepresented in studies of left ventricular assist devices (LVADs). Only 9 percent to 16 percent of participants in trials of the first generation of the device were women.

The new trial included 231 patients with heart failure, 23 percent of whom were women being treated at one of 40 different U.S. heart transplant centers and were awaiting heart transplants. The device serves as a "bridge" to transplantation.

The average age of the women was 56 (the range was 20 to 69 years). Men in the study averaged 54 years old, with an age range of 17 to 68.

Coronary artery disease was more likely to be the cause of heart failure in men -- 43 percent, compared with 31 percent in women.

The women may have suffered a weakened heart because of pregnancy, cancer chemotherapy, a viral infection or some other unknown cause, the researchers said.

Several study participants regained enough pumping power in the heart to have the device removed and no longer needed a transplant. And they've resumed normal physical activities, said the study authors, who are affiliated with such research centers as the Texas Heart Institute in Houston; the University of Rochester in New York; Johns Hopkins Hospital in Baltimore; Duke University, in Durham, N.C.; and Massachusetts General Hospital, in Boston.

Among the study's other findings:

  • Six-month survival was about the same for men and women -- 80.6 percent versus 79.5 percent.
  • The study found that 3.3 percent of women and 2.2 percent of men experienced strokes within two days of surgery; 13.6 percent of women and 4 percent of men experienced strokes after that.
  • After three months with the device, 76 percent of women and 57 percent of men had increased the distance they could walk in six minutes by more than 200 meters. "Functionally, it helped women more than men," Steinbaum said.
  • At the beginning of the study, all patients had Class IV heart failure, meaning they couldn't engage in any physical activity without discomfort. After three months with the device, 84 percent of women and men had only Class I and Class II heart failure symptoms -- no or slight limitations on physical activity. "Eighty-four percent of men and women went from Class IV heart failure -- they couldn't even move without being short of breath -- to Class I and II," Steinbaum said. "It's very exciting."

The trial was funded by Thoratec Corp. of Pleasanton, Calif., which manufactures the device. One of the study authors is the company's vice president for research and scientific affairs. The other study authors are consultants and serve on a Thoratec advisory board.

More information

The American Heart Association has more on left ventricular assist devices.



SOURCES: Suzanne Steinbaum, M.D., director, Women and Heart Disease, Lenox Hill Hospital, New York City; Nov. 4, 2007, presentation, American Heart Association annual meeting, Orlando, Fla.


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Epileptic Seizures Can Be Duec to Heart Problem
3. Bypass Heart Surgery Performed Without General Anesthesia
4. New CPR Guidelines issued by Heart Association
5. White Cells Count Can Predict Heart Attack Death Risk
6. Vitamins-The answer to Heart Disease?
7. Fight Heart disease and Pain with Meditation
8. Heart disease in the newborn is related to maternal malnutrition
9. New drug to treat Heart Attack and damaged tissue
10. Starvation in pregnant women can cause heart disease to their children
11. Individuals with sleep related breathing disorders more prone to heart disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Heart Pump Helps Women Awaiting Transplants
(Date:2/8/2016)... GA (PRWEB) , ... February 08, 2016 , ... Coast ... cavity-free. February is National Children’s Dental Health Month and family dentist Yvonne Dorrian, DMD, ... p.m. at Coast Dental , located next to Target at 1207 North Peachtree ...
(Date:2/8/2016)... ... 08, 2016 , ... The Valentine’s Season is famous for gift giving with flowers, chocolates and ... are loved. This year, for more than 5.6 million Americans suffering with Alzheimer’s, those ... enough to remind them of the lives they’ve led and the people they’ve touched. ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... case packer for pouches, bags, and flow wrapped products at WestPack 2015, February ... specialty product manufacturers step up to semi-automatic or fully-automatic case packing with a ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... expansion into Canada to provide its range of unique and advantaged protective ... Quebec City that will provide bilingual customer service and marketing support. A new ...
(Date:2/8/2016)... ... February 08, 2016 , ... The Bell Agency, ... the latest beneficiary of their ongoing community enrichment program. The current campaign fundraises ... schools. Donations are now being accepted at: http://www.angelsanddoves.com/donate.html . , Angels & ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... 2016 Cardiovascular Surgery Devices - Medical ... Medical Devices sector report, "Cardiovascular Surgery Devices - ... of Cardiovascular Surgery Devices currently in pipeline stage. ... The report provides comprehensive information on the pipeline ... various stages of development. The report reviews major ...
(Date:2/8/2016)... TOKYO and FAIRFIELD, N.J. ... (Otsuka) and Medimetriks Pharmaceuticals, Inc. (Medimetriks) today announced that ... exclusive development and commercialization rights for OPA-15406 in the ... agreement also provides manufacturing rights.  OPA-15406 is a topical, ... for atopic dermatitis. --> ...
(Date:2/8/2016)... February 8, 2016 --> ... research report "Ablation Technologies Market by Product (Radiofrequency, Ultrasound, ... Management, Cosmetic Surgery, Ophthalmology, Gynecology) - Global Forecasts to ... market over the forecast period of 2015 to 2020. ... 2020, at CAGR of 10.5% from 2015 to 2020. ...
Breaking Medicine Technology: